These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 32979387)
21. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M; J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377 [TBL] [Abstract][Full Text] [Related]
23. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes. Edstedt Bonamy AK; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M; Neonatology; 2017; 111(4):367-375. PubMed ID: 28125815 [TBL] [Abstract][Full Text] [Related]
24. PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. Clyman RI; Liebowitz M; Kaempf J; Erdeve O; Bulbul A; Håkansson S; Lindqvist J; Farooqi A; Katheria A; Sauberan J; Singh J; Nelson K; Wickremasinghe A; Dong L; Hassinger DC; Aucott SW; Hayashi M; Heuchan AM; Carey WA; Derrick M; Fernandez E; Sankar M; Leone T; Perez J; Serize A; J Pediatr; 2019 Feb; 205():41-48.e6. PubMed ID: 30340932 [TBL] [Abstract][Full Text] [Related]
26. Clinical Correlates of Moderate-to-Severe Bronchopulmonary Dysplasia in Preterm Infants following Surgical Necrotizing Enterocolitis. Garg PM; Pippin M; Zhang M; Ware J; Nelin S; Paschal J; Varshney N; Hillegass WB Am J Perinatol; 2024 Jul; 41(10):1348-1358. PubMed ID: 35858647 [TBL] [Abstract][Full Text] [Related]
27. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. Choi CW; Kim BI; Kim HS; Park JD; Choi JH; Son DW Acta Paediatr; 2006 Jan; 95(1):38-43. PubMed ID: 16373294 [TBL] [Abstract][Full Text] [Related]
28. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. Clyman R; Cassady G; Kirklin JK; Collins M; Philips JB J Pediatr; 2009 Jun; 154(6):873-6. PubMed ID: 19324366 [TBL] [Abstract][Full Text] [Related]
29. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. Liebowitz M; Clyman RI J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025 [TBL] [Abstract][Full Text] [Related]
30. [Patent ductus arteriosus in premature infants]. Bratlid D; Farstad T Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594 [TBL] [Abstract][Full Text] [Related]
32. Late pulmonary tomography assessment in premature infants with bronchopulmonary dysplasia submitted to patent ductus arteriosus management. Beani L; Moscardini AC; Souza AS; Souza AS; Yamamoto AE; Croti UA; Braile DM Rev Bras Cir Cardiovasc; 2007; 22(4):400-6. PubMed ID: 18488106 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment. Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140 [TBL] [Abstract][Full Text] [Related]
34. Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Chock VY; Punn R; Oza A; Benitz WE; Van Meurs KP; Whittemore AS; Behzadian F; Silverman NH Pediatr Res; 2014 Apr; 75(4):570-5. PubMed ID: 24378897 [TBL] [Abstract][Full Text] [Related]
35. Dose pulmonary hemorrhage increase the risk of bronchopulmonary dysplasia in very low birth weight infants? Pan JJ; Zou YS; Tong ML; Wang J; Zhou XY; Cheng R; Yang Y J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2206941. PubMed ID: 37121909 [TBL] [Abstract][Full Text] [Related]
36. Patent ductus arteriosus and respiratory outcome in premature infants. Bancalari E; Claure N; Gonzalez A Biol Neonate; 2005; 88(3):192-201. PubMed ID: 16210841 [TBL] [Abstract][Full Text] [Related]
38. Outcomes among preterm infants with patent ductus arteriosus: Relationship with treatment, gestational age, hemodynamic status and timing of treatment. Chikkabyrappa SM; Chaudhary N; Agarwal A; Rastogi D; Filipov P; Rastogi S J Neonatal Perinatal Med; 2022; 15(2):219-227. PubMed ID: 34719442 [TBL] [Abstract][Full Text] [Related]
39. Risk factors that affect the degree of bronchopulmonary dysplasia: Comparison by severity in the same gestational age. Kim SH; Han YS; Chun J; Lee MH; Sung TJ PLoS One; 2020; 15(7):e0235901. PubMed ID: 32673340 [TBL] [Abstract][Full Text] [Related]
40. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]